The FDA recommended trials when the ban was lifted. However, these trials were not done and were not done properly.
We had an FDA meeting, I think, three or four years ago where I was also a witness. There, many patients came forward and said they participated in these trials, but as soon as they developed complications, they were sent out of the trial because they had complications. Those are not proper trials.